MBUU vs TSLA

MBUU presents a stark contrast between a pristine balance sheet and a deteriorating income statement, highlighted by a perfect Piotroski F-Score of 9/9. While the company maintains exceptional financial health with negligible debt (Debt/Equity 0.05) and trades near book value (P/B 0.97), it is struggling with negative operating margins and a severe collapse in YoY EPS growth (-116.7%). The valuation is fragmented, with a Graham Number of $21.05 suggesting slight overvaluation, while the Forward P/E of 12.60 indicates an expected earnings recovery. Ultimately, the stock is a deep-value play contingent on a cyclical rebound in the recreational vehicle market.

Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.